Skip to main content

Leukemia News (Page 5)

Related terms: Cancer, Leukemia

FDA Approves Iclusig to Treat Two Rare Types of Leukemia

December 14, 2012 - The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute...

FDA Approves Bosulif for Chronic Myelogenous Leukemia

September 4, 2012 – The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older...

FDA Approves Marqibo for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia

August 9, 2012 – The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome...

FDA Approves Erwinaze to Treat Acute Lymphoblastic Leukemia

November 18, 2011 – The U.S. Food and Drug Administration today approved Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Chronic Myelogenous Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hairy Cell Leukemia, Blood Disorders

Related drug support groups

prednisone, triamcinolone, dexamethasone